Nan Fung Trinity (Hk) LTD Gilead Sciences, Inc. Transaction History
Nan Fung Trinity (Hk) LTD
- $449 Million
- Q2 2024
A detailed history of Nan Fung Trinity (Hk) LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Nan Fung Trinity (Hk) LTD holds 133,700 shares of GILD stock, worth $11.3 Million. This represents 2.04% of its overall portfolio holdings.
Number of Shares
133,700Holding current value
$11.3 Million% of portfolio
2.04%Shares
3 transactions
Others Institutions Holding GILD
# of Institutions
1,880Shares Held
1.02BCall Options Held
12MPut Options Held
8.96M-
Black Rock Inc. New York, NY121MShares$10.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$9.7 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.42 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.09 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$4.99 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $105B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...